Anderberg et al
Preclinical research in rodents demonstrated that long-term, high-dose exposure to GLP-1 receptor agonists was associated with thyroid C-cell tumours (medullary thyroid carcinoma)
As a result, you lose even more weight than tirzepatide.
Galindo RJ, Moazzami B, Scioscia MF, Zambrano C, Albury BS, Saling J, Vellanki P, Pasquel FJ, Davis GM, Fayfman M, Peng L, Umpierrez GE
Although GLP-1RAs are well established for treating obesity, type 2 diabetes, and for reducing cardiovascular risk, their potential role in inflammatory diseases such as RA has not been clearly defined
Good Candidates BMI of 30 or higher (obesity) BMI of 27+ with weight-related conditions Looking for more aggressive weight loss than semaglutide Haven't reached goals with other GLP-1 medications Committed to lifestyle changes alongside medication Not Recommended For Personal or family history of medullary thyroid cancer Multiple Endocrine Neoplasia syndrome type 2 (MEN2) History of pancreatitis or gallbladder disease Pregnant or planning to become pregnant Currently breastfeeding Tirzepatide Cost at Highland Longevity Transparent pricing with no hidden fees
